The ANGELS Initiative: More and better Stroke-ready hospitals across the globe

by Ket Patel | Dec 21, 2018 | Uncategorized

Established by Boehringer Ingelheim in 2015, in collaboration with international stroke experts and the European Stroke Organisation (ESO), the Acute Networks StrivinG for ExceLlence in Stroke (ANGELS) project has had a major impact on expanding available treatment...

Innovations in Endovascular Treatment of Acute Ischemic Stroke and Cerebral Aneurysms

by Ket Patel | Dec 21, 2018 | Uncategorized

Technological innovations are optimizing endovascular treatment of patients with acute ischemic stroke (AIS) and cerebral aneurysms.

Clinical Outcomes and Work Flow Optimisation with Pipeline System and Shield Technology

by Ket Patel | Dec 21, 2018 | Uncategorized

Endovascular treatment is the treatment of choice for many intracerebral aneurysms (ICAs). However, coiling is probably less effective for giant or wide-necked aneurysms, and retreatment is not uncommon. Flow diversion (FD) is a novel endovascular approach to ICA...

Stroke Prevention and Treatment: New Insights into NOACs and Reversal

by Ket Patel | Aug 2, 2018 | Uncategorized

Non-vitamin-K oral anticoagulants (NOACs) have become the standard of care in stroke prevention for individuals with atrial fibrillation (AF).

Embolic Stroke of Undetermined Source (ESUS)

by Ket Patel | Aug 2, 2018 | Uncategorized

Embolic stroke of undetermined source (ESUS) is a subset of cryptogenic stroke. Recurrence rates are high following ESUS and the optimal treatment to reduce the risk of recurrent stroke depends on the pathophysiology of the index stroke.